Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial to Quantify the Efficacy of the Safetac® Product Mepitel® Film on the Prevention of Radiodermatitis in the Inguinal Fold.

NCT04617730 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT04617730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04617730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial to Quantify the Efficacy of the Safetac® Product Mepitel® Film on the Prevention of Radiodermatitis in the Inguinal Fold.
Lead sponsor
Jules Bordet Institute
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 1, 2021
Completion date
January 1, 2025
Enrollment
35 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

radiation toxicity, radiodermatitis, radiotherapy side effect